2-(3-(Trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid

Catalog No. :
ACYBME586
CAS No. :
333309-24-3
Molecular Formula :
C9H9F3N2O2
Molecular Weight :
234.18

IUPAC Name:2-(3-(trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid

2-(3-(Trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$168.00Login to see priceInquiryInquiry
1g95%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-(Trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid
IUPAC Name2-(3-(trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid
MDL No.MFCD02732817
Molecular FormulaC9H9F3N2O2
Molecular Weight234.18
SMILESO=C(O)CN1N=C(C(F)(F)F)C2=C1CCC2
InChI KeyJJVIKYVCIPXTOK-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB011685;(3-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-CYCLOPENTA-PYRAZOL-1-YL)-ACETIC ACID;[3-(trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl]acetic acid;2-(3-(Trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)acetic acid;1(4H)-Cyclopentapyrazoleacetic acid, 5,6-dihydro-3-(trifluoromethyl)-
CAS No.333309-24-3
PubChem CID653577

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYBME586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYBME586 route product structure diagram
    ACYBME586333309-24-3
Inquiry

2. ACYBME586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYBME586 route product structure diagram
    ACYBME586333309-24-3
Inquiry

Comments (0)